Mandate

Vinge advised Ernström & C:o

December 02, 2017 M&A

Vinge has advised Ernström & C:o in conjunction with the investment and acquisition of shares in CellMark Investment.

Ernström is a Gothenburg-based investment company which is owned by the Hobohm Hielte family. CellMark is a global trading house within chemicals, paper, pulp, metals, packaging, recycling, energy and pharmaceuticals. Ernström has acquired almost one quarter of CellMark.

Vinge’s team consisted of responsible partner Olof Jisland together with associates Filip Öhrner, Daniel Lennartsson, André Isacson, Sara Strandberg, Filip Markhed and VDR assistant Sofie Sundin.

Related

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026

Vinge has advised Resurs in connection with its strategic partnership with Kustom

Vinge has advised Resurs in connection with its strategic partnership with Kustom (formerly Klarna Checkout), a fast-growing player in the digital commerce sector. The partnership enables Resurs to accelerate its strategic development by offering a check-out solution to its merchants, built on Kustom’s market-leading infrastructure.
March 25, 2026

Vinge has advised Morrow Bank AB (publ) in conjunction with the acquisition of MedMera Bank AB

Vinge has advised Morrow Bank AB (publ) in conjunction with the acquisition of all shares in MedMera Bank AB from Kooperativa Förbundet for a total consideration of SEK 1,960 million. The transaction positions Morrow Bank as a leading Nordic platform in consumer finance with combined gross loans of SEK 28.2 billion.
March 24, 2026